These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 16445299)

  • 1. Bayesian methods for evidence synthesis in cost-effectiveness analysis.
    Ades AE; Sculpher M; Sutton A; Abrams K; Cooper N; Welton N; Lu G
    Pharmacoeconomics; 2006; 24(1):1-19. PubMed ID: 16445299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.
    Chen YF; Madan J; Welton N; Yahaya I; Aveyard P; Bauld L; Wang D; Fry-Smith A; Munafò MR
    Health Technol Assess; 2012; 16(38):1-205, iii-v. PubMed ID: 23046909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
    Leaviss J; Sullivan W; Ren S; Everson-Hock E; Stevenson M; Stevens JW; Strong M; Cantrell A
    Health Technol Assess; 2014 May; 18(33):1-120. PubMed ID: 24831822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service.
    Peckham E; Man MS; Mitchell N; Li J; Becque T; Knowles S; Bradshaw T; Planner C; Parrott S; Michie S; Shepherd C; Gilbody S
    Health Technol Assess; 2015 Mar; 19(25):1-148, v-vi. PubMed ID: 25827850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian cost-effectiveness analysis from clinical trial data.
    O'Hagan A; Stevens JW; Montmartin J
    Stat Med; 2001 Mar; 20(5):733-53. PubMed ID: 11241573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a specialist smoking cessation package compared with standard smoking cessation services for people with severe mental illness in England: a trial-based economic evaluation from the SCIMITAR+ study.
    Li J; Fairhurst C; Peckham E; Bailey D; Arundel C; Hewitt C; Heron P; Crosland S; Parrott S; Gilbody S;
    Addiction; 2020 Nov; 115(11):2113-2122. PubMed ID: 32319154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An illustration of the modelling of cost and efficacy data from a clinical trial.
    Hahn S; Whitehead A
    Stat Med; 2003 Mar; 22(6):1009-24. PubMed ID: 12627415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Evidence for Key Parameters in Decision-Analytic Models of Cost Effectiveness: A Description of Sources and a Recommended Minimum Search Requirement.
    Paisley S
    Pharmacoeconomics; 2016 Jun; 34(6):597-608. PubMed ID: 26861793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial factorial trials: comparing methods for statistical analysis and economic evaluation.
    Dakin HA; Gray AM; MacLennan GS; Morris RW; Murray DW
    Trials; 2018 Aug; 19(1):442. PubMed ID: 30115104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies.
    O'Hagan A; Stevens JW
    Stat Methods Med Res; 2002 Dec; 11(6):469-90. PubMed ID: 12516985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
    Wang D; Connock M; Barton P; Fry-Smith A; Aveyard P; Moore D
    Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whither trial-based economic evaluation for health care decision making?
    Sculpher MJ; Claxton K; Drummond M; McCabe C
    Health Econ; 2006 Jul; 15(7):677-87. PubMed ID: 16491461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application.
    Sculpher M; Fenwick E; Claxton K
    Pharmacoeconomics; 2000 May; 17(5):461-77. PubMed ID: 10977388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analysis of multinational cost-effectiveness data for reimbursement decisions: a critical appraisal of recent methodological developments.
    Manca A; Sculpher MJ; Goeree R
    Pharmacoeconomics; 2010; 28(12):1079-96. PubMed ID: 21080734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Decision analytic modeling and their impact on health care decision making].
    Inotai A; Kaló Z; Mészáros A
    Acta Pharm Hung; 2009; 79(2):63-9. PubMed ID: 19634636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of a brief counselling for smoking cessation in dentistry: a case study comparing two health economic models.
    Virtanen SE; Galanti MR; Johansson PM; Feldman I
    BMJ Open; 2017 Jul; 7(7):e016375. PubMed ID: 28729321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.